Daratumumab manufacturers
- Daratumumab
-
- $147.00 / 1mg
-
2024-11-04
- CAS:945721-28-8
- Min. Order:
- Purity: 98.60%
- Supply Ability: 10g
- Daratumumab USP/EP/BP
-
- $1.10 / 1g
-
2021-08-18
- CAS:945721-28-8
- Min. Order: 1g
- Purity: 99.9%
- Supply Ability: 100 Tons min
- Daratumumab
-
- $5.00 / 1g
-
2020-08-21
- CAS:945721-28-8
- Min. Order: 1KG
- Purity: 99%min
- Supply Ability: 5000 Kilogram/Kilograms per Month
|
| | Daratumumab Basic information |
| Product Name: | Daratumumab | | Synonyms: | Daratumumab;Daratumumab - 20mg/ml in water;Daratumumab 21.7mg/ml;Daratumumab USP/EP/BP;Research Grade Daratumumab(DHD80801);Anti-Human CD38, Human Antibody,myeloma,inhibit,tumor,antibody,cell,adhesion,cytotoxicity,Inhibitor,Daratumumab | | CAS: | 945721-28-8 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Daratumumab Structure]() |
| | Daratumumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow | | CAS DataBase Reference | 945721-28-8 |
| | Daratumumab Usage And Synthesis |
| Clinical Use | Human monoclonal IgG1κ antibody against CD38
antigen:
Treatment of multiple myeloma | | Drug interactions | Potentially hazardous interactions with other drugs
Vaccines: avoid with live vaccines. | | Metabolism | No data |
| | Daratumumab Preparation Products And Raw materials |
|